Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
FAI releases comprehensive food allergy guidelines

FAI releases comprehensive food allergy guidelines

FDA accepts for review Bristol-Myers Squibb's ORENCIA sBLA for severe RA

FDA accepts for review Bristol-Myers Squibb's ORENCIA sBLA for severe RA

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

AMAG updates product label of Feraheme Injection

AMAG updates product label of Feraheme Injection

Phase 3 trial: TYSABRI improves vision in MS patients

Phase 3 trial: TYSABRI improves vision in MS patients

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Social limitation troubles teens with food allergies: Study

Social limitation troubles teens with food allergies: Study

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Food allergies may lead to 'kissing' allergies

Food allergies may lead to 'kissing' allergies

50% of nut allergic patients not able to recognize nut types

50% of nut allergic patients not able to recognize nut types

Study finds children more likely to be allergic to amoxicillin

Study finds children more likely to be allergic to amoxicillin

Combination of Chinese herbal formula and conventional treatments may help treat food allergies

Combination of Chinese herbal formula and conventional treatments may help treat food allergies

Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting

Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting

Plant-based respiratory allergies on the rise due to climate change

Plant-based respiratory allergies on the rise due to climate change

ACAAI scientific meeting to discuss pediatric allergies

ACAAI scientific meeting to discuss pediatric allergies

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Merz to present data on Xeomin clinical studies for cervical dystonia at AAPM&R

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

FDA approves Teflaro for treatment of community-acquired bacterial pneumonia

FDA approves Teflaro for treatment of community-acquired bacterial pneumonia

Innovative program for new graduate doctors to ensure safety prescription

Innovative program for new graduate doctors to ensure safety prescription